GLP-1 War: A Look At The Epic Pipeline Battle Between Novo Nordisk And Eli Lilly

Analyst's Disclosure:I/we have a beneficial long position in the shares of NVO, MCD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. I have been investing in Novo Nordisk ( NVO ) since it was trading at $80 per share. Back then I thought I was getting a bargain, and despi ...